Amy M. Miller. Ph.D. retweeted
#PhF26 awardee Thalia Newman, a PhD student @umichmedicine, is investigating the immune system’s role in antiphospholipid syndrome (APS), an autoimmune disease that causes blood clots. She hopes her research can help identify new treatments.
Learn more: phrmafoundation.org/news-eve…
Amy M. Miller. Ph.D. retweeted
Congratulations to M.D.-Ph.D. student Kijung Kwak, who received a 2026 @PhRMAfoundation fellowship to advance a new approach to gene therapy for Parkinson’s disease in the UMSOM lab of Jung Soo Suk, PhD.
ow.ly/8Xle5105VtH
#Parkinsons #GeneTherapy
Amy M. Miller. Ph.D. retweeted
#PhF26 awardee @PrernaTiwari01, a PhD student @Creighton, is exploring new approaches to protect the #brain from damage caused by a lack of blood flow, which can occur after cardiac arrest.
Read this Q&A to learn about Prerna and her research: phrmafoundation.org/news-eve…
Amy M. Miller. Ph.D. retweeted
Federal law protects voting rights. If the polls close while you’re in line, stay in line — you have the right to vote no matter how long the wait is.
Know your rights while voting today by following these guidelines: wapo.st/4BLdki0
Amy M. Miller. Ph.D. retweeted
How have GLP-1s changed patient views on weight-loss treatments?
#PhF26 awardee Neeti Kulkarni, a PhD student @umichsph, is conducting research to measure how people value different #obesity-related health outcomes and treatments.
Learn more: phrmafoundation.org/news-eve…
Amy M. Miller. Ph.D. retweeted
I’m recruiting a Postdoctoral Fellow to join my lab at the Harvard T.H. Chan School of Public Health, working on innate immunity to RNA viruses.
To apply, please email a CV and a letter of interest to [email protected]. Details: academicpositions.harvard.ed…
Can’t wait to see your ideas!
Today's the day! LOIs are due to @PhRMAFoundation by 12 pm ET today for the Predoctoral and Postdoctoral funding opportunities: bit.ly/4dp7dFn
1
56
Amy M. Miller. Ph.D. retweeted
#PhF26 awardee Melanie Martinsen, an MD-PhD student @BrownUniversity, is researching a cell-based therapy for people vulnerable to infection due to low levels of neutrophils, infection-fighting white blood cells.
Watch the full interview: phrmafoundation.org/news-eve…
@MMartinsen1719
Amy M. Miller. Ph.D. retweeted
DEADLINE IN ONE WEEK
Don't miss your chance to submit a letter of intent for our 2027 predoctoral and postdoctoral fellowships in drug discovery, drug delivery, and translational medicine.
Deadline: October 30 @ 12 p.m. (noon) ET
Learn more and submit: phrmafoundation.org/grants-f…
Earlier today the @PhRMAfoundation announced an expansion. Here's a link to learn more and apply. Can't wait to see your ideas!
📣 SPREAD THE WORD 📣
The PhRMA Foundation has just launched a 2nd funding cycle so that we can award more predoctoral & postdoctoral fellowships in 2027.
We are now accepting LOIs in 🔬 Drug Discovery, 💊 Drug Delivery, and 🧬 Translational Medicine!
phrmafoundation.org/grants-f…
Amy M. Miller. Ph.D. retweeted
Our team is incredibly excited for this expansion to fund many more early-career researchers! I spend a lot of time interviewing our awardees, and I am continually impressed by their ambition and passion. I cannot wait to meet the next round of awardees!
A strong scientific workforce is critical for America's leadership in biomedical innovation.
That's why biopharmaceutical companies have pledged +$16M to support a historic @PhRMAfoundation effort to invest in 500 early-career researchers over 3 years.
phrmafoundation.org/news-eve…
Amy M. Miller. Ph.D. retweeted
#PhF26 awardee Kelly O’Rourke, a PhD student @VanderbiltU, aims to uncover how a key protein helps protect the brain’s dopamine-producing cells, w/ a goal of finding new treatments for Parkinson’s disease. @VUBasicSciences
Learn more in our Q&A w/ Kelly: phrmafoundation.org/news-eve…
Be kind to your grant application reviewers. Format that citation list for human consumption. Thank you.
39
Amy M. Miller. Ph.D. retweeted
#PhF26 awardee @ElvisDuru2, a PhD student @uofupharmacy, is researching how insurance policies can hinder patient access to new GLP-1 drugs for #obesity. He will interview patients & providers about their experiences w/ denials, delays, appeals & costs.
phrmafoundation.org/news-eve…
In fairness, lots of great information for turning a CV into a resume.
A strong resume can open doors to a career in the pharmaceutical industry. Watch our latest webinar for actionable tips on translating your academic CV into a resume that catches the attention of company hiring managers.
phrmafoundation.org/news-eve…
38
Amy M. Miller. Ph.D. retweeted
9:37 a.m., the moment of impact at the Pentagon, where 184 lives were lost. #NeverForget
📷: Navy Photos - Michael Pendergrass
Amy M. Miller. Ph.D. retweeted
Replying to @PhRMAfoundation @AmyMillerPhD
It is a very informative article. Thank you so much for your work and your support of patient engagement in value assessment research.
Amy M. Miller. Ph.D. retweeted
Patient engagement is essential to high-quality #HEOR & value assessment research. A new @PhRMAfoundation commentary in The Patient provides a practical roadmap for incorporating meaningful patient engagement into research proposals.
Learn more: phrmafoundation.org/news-eve…
Amy M. Miller. Ph.D. retweeted
We are now accepting applications for our 2027 Value Assessment & Health Outcomes Research awards.
Join our informational session this Thursday, Sept. 3, at 12 p.m. ET to learn about these funding opportunities for predocs and postdocs.
REGISTER: phrma.zoom.us/webinar/regist…
A milestone worth celebrating. For decades, RAS was considered “undruggable.” Today, patients with metastatic pancreatic cancer have a new targeted treatment option.
Our story:
FDA approves new pancreatic cancer drug expected to usher in new era of treatment
The therapy, Rasonque from Revolution Medicines $RVMD, nearly doubled overall survival in a key clinical trial
statnews.com/2026/08/26/panc…






















